MedTrace Logo

Global Myofascial Treatment With Shockwave for Non-Specific Low Back Pain

NCT07692347 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-07-16

No results posted yet for this study

Summary

This study aims to examine the effects of shockwave therapy on myofascial tissue (muscles, fascia, and connective tissue), focusing on pain reduction and improvement of mobility. The results will be compared with those of conventional manual physiotherapy.

Myofascial tissue can be a source of back pain, as it may contain painful spots known as myofascial trigger points (MTrPs). Shockwave therapy can stimulate these trigger points, potentially leading to muscle and fascia relaxation and, as a result, a decrease in pain.

The study investigates how focused shockwave trigger point therapy influences back function and pain perception compared to traditional physiotherapeutic treatment.

Participation is voluntary. The examinations will only be carried out if you provide written informed consent. You may refuse participation or withdraw your consent at any time without any disadvantages.

Conditions

  • Low Back Pain

Interventions

DEVICE

Shockwave therapy

Shockwave therapy can stimulate these trigger points, potentially leading to muscle and fascia relaxation and, as a result, a decrease in pain.

PROCEDURE

Conventional physiotherapy

Conventional physiotherapy to treat low back pain

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Richard Stange, Prof. · Institut für Muskuloskelettale Medizin (IMM) Abteilung für Muskuloskelettale Regenerative Medizin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2022-12-31
Completion
2026-04-15

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07692347 on ClinicalTrials.gov